Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Adams

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
BMC Systems Biology|December 17, 2011
Reproducible computational biology experiments with SED-ML--the Simulation Experiment Description Markup LanguageDagmar Waltemath, Richard Adams, Frank T Bergmann, et al.
Journal of Clinical Pathology|September 10, 2015
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trialSusan D Richman, Richard Adams, Phil Quirke, et al.
International Journal of Radiation Oncology, Biology, Physics|October 21, 2019
Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell CarcinomaRebecca Shakir, Richard Adams, Rachel Cooper, et al.
Plos One|September 26, 2018
Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?Peter C Elwood, Janet E Pickering, Gareth Morgan, et al.
Clinical Colorectal Cancer|June 13, 2026
Prognostic Value of Liver Metastases and KRAS Mutations in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Third-Line Placebo-Controlled Trials From the ARCAD CRC DatabaseThomas Samaille, Morteza Raeisi, Romain Cohen, et al.
British Journal of Cancer|August 18, 2018
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUSSimon Gollins, Nicholas West, David Sebag-Montefiore, et al.
The Lancet. Oncology|April 8, 2014
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trialHarpreet Wasan, Angela M Meade, Richard Adams, et al.
Disability and Health Journal|November 24, 2025
Factors associated with a decline in ambulatory status among children and adults with Spina Bifida in the National Spina Bifida Patient RegistryMichael Conklin, Betsy Hopson, Jonathan Castillo, et al.
Journal of Cancer Policy|June 19, 2022
Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancerRaymond H Henderson, Declan French, Ethna McFerran, et al.
Bioinformatics (Oxford, England)|January 19, 2013
SBSI: an extensible distributed software infrastructure for parameter estimation in systems biologyRichard Adams, Allan Clark, Azusa Yamaguchi, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
BMC Systems Biology|December 17, 2011
Reproducible computational biology experiments with SED-ML--the Simulation Experiment Description Markup LanguageDagmar Waltemath, Richard Adams, Frank T Bergmann, et al.
Journal of Clinical Pathology|September 10, 2015
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trialSusan D Richman, Richard Adams, Phil Quirke, et al.
International Journal of Radiation Oncology, Biology, Physics|October 21, 2019
Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell CarcinomaRebecca Shakir, Richard Adams, Rachel Cooper, et al.
Plos One|September 26, 2018
Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?Peter C Elwood, Janet E Pickering, Gareth Morgan, et al.
Clinical Colorectal Cancer|June 13, 2026
Prognostic Value of Liver Metastases and KRAS Mutations in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Third-Line Placebo-Controlled Trials From the ARCAD CRC DatabaseThomas Samaille, Morteza Raeisi, Romain Cohen, et al.
British Journal of Cancer|August 18, 2018
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUSSimon Gollins, Nicholas West, David Sebag-Montefiore, et al.
The Lancet. Oncology|April 8, 2014
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trialHarpreet Wasan, Angela M Meade, Richard Adams, et al.
Disability and Health Journal|November 24, 2025
Factors associated with a decline in ambulatory status among children and adults with Spina Bifida in the National Spina Bifida Patient RegistryMichael Conklin, Betsy Hopson, Jonathan Castillo, et al.
Journal of Cancer Policy|June 19, 2022
Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancerRaymond H Henderson, Declan French, Ethna McFerran, et al.
Bioinformatics (Oxford, England)|January 19, 2013
SBSI: an extensible distributed software infrastructure for parameter estimation in systems biologyRichard Adams, Allan Clark, Azusa Yamaguchi, et al.
Pageof 15